Provision of Inherited White Matter Disorders Diagnostic and Management Service (IWMD) (All Ages) Re-opened from previous EU Supply Reference 45233

• Value: £358K

Lot 1: Adult care - one provider for the NHS England populations in the following Regions: a. The North West; b. The North East and Yorkshire; c. The Midlands; and d. The north part of the East of England Region including Cambridge NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process. … Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions. New bidders are required to submit responses to all of the questions. The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”). The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.

• Value: £392K

Adult care: one provider for the NHS England populations in the following Regions: a. London; b. The South East; c. The South West; and d. The southern part of the East of England Region including Essex NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process. … Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions. New bidders are required to submit responses to all of the questions. The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”). The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.

• Value: £358K

Paediatric care: one provider for the NHS England populations in the following Regions: a. The North West; and b. The North East and Yorkshire NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process. … Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions. New bidders are required to submit responses to all of the questions. The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”). The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.

• Value: £358K

Paediatric care: one provider for the NHS England populations in the following Regions: a. The Midlands; and b. The north part of the East of England Region including Cambridge NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process. … Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions. New bidders are required to submit responses to all of the questions. The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”). The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.

• Value: £392K

Paediatric care: one provider for the NHS England populations in the following Regions: a. London; b. The South West; c. The South East; and d. The southern part of the East of England area including Essex NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process. … Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions. New bidders are required to submit responses to all of the questions. The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”). The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.

• Value: £53K

One provider to host the IWMD Clinical Registry. Note: The award of Lot 6 can only be made to a provider that is successful in one or more of Lots 1 to 5. NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process. … Previous bidders are invited to confirm the non-financial responses they have already submitted or amend these if they so wish. They are asked to respond to the new financial questions. New bidders are required to submit responses to all of the questions. The provider selection process is described within the documentation published. This Provider Selection Process has been advertised in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services (also known as the “Light Touch Regime”). The key objective of the provider selection is to commission the Service(s) to serve the population of England. It is expected that expert care for rare Inherited White Matter Disorders (IWMDs) will already be being provided by the organisations which apply to this process and applicants will be able to demonstrate this. For this reason, applying organisations must be existing tertiary neurosciences units.